[go: up one dir, main page]

NO20054763L - Salter av clopidogrel og fremgangsmate for fremstilling derav - Google Patents

Salter av clopidogrel og fremgangsmate for fremstilling derav

Info

Publication number
NO20054763L
NO20054763L NO20054763A NO20054763A NO20054763L NO 20054763 L NO20054763 L NO 20054763L NO 20054763 A NO20054763 A NO 20054763A NO 20054763 A NO20054763 A NO 20054763A NO 20054763 L NO20054763 L NO 20054763L
Authority
NO
Norway
Prior art keywords
clopidogrel
preparation
salts
clopidogreltosylate
medicine
Prior art date
Application number
NO20054763A
Other languages
English (en)
Other versions
NO333586B1 (no
NO20054763D0 (no
Inventor
Braj Bhushan Lohray
Vidya Bhushan Lohray
Mayank Ghanshyambhai Dave
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Publication of NO20054763D0 publication Critical patent/NO20054763D0/no
Publication of NO20054763L publication Critical patent/NO20054763L/no
Publication of NO333586B1 publication Critical patent/NO333586B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Sammendrag Det beskrives nye salter av clopidogrel, nemlig clopidogrel-mesylat, clopidogrelbesylat og clopidogreltosylat, videre fremgangsmåter for deres fremstilling, samt farmasøytiske preparater inneholdende forbindelsene og deres anvendelse i medisin. (Fig. 1)
NO20054763A 2003-04-25 2005-10-17 Krystallinsk clopidogrel og fremgangsmate for fremstilling derav NO333586B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN413MU2003 2003-04-25
PCT/IN2004/000112 WO2004106344A2 (en) 2003-04-25 2004-04-22 Salts of clopidogrel and process for preparation

Publications (3)

Publication Number Publication Date
NO20054763D0 NO20054763D0 (no) 2005-10-17
NO20054763L true NO20054763L (no) 2006-01-16
NO333586B1 NO333586B1 (no) 2013-07-15

Family

ID=33485475

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054763A NO333586B1 (no) 2003-04-25 2005-10-17 Krystallinsk clopidogrel og fremgangsmate for fremstilling derav

Country Status (13)

Country Link
US (2) US7732608B2 (no)
EP (4) EP2113506A3 (no)
KR (1) KR20060013376A (no)
CY (1) CY1116554T1 (no)
DE (1) DE04770646T1 (no)
DK (1) DK1618111T3 (no)
ES (1) ES2531088T3 (no)
HR (1) HRP20150056T1 (no)
NO (1) NO333586B1 (no)
PL (1) PL1618111T3 (no)
PT (1) PT1618111E (no)
SI (1) SI1618111T1 (no)
WO (1) WO2004106344A2 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
EP1603920A1 (en) * 2003-03-12 2005-12-14 Cadila Healthcare Ltd. Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
PL1618111T3 (pl) 2003-04-25 2015-06-30 Cadila Healthcare Ltd Sole klopidogrelu i sposób wytwarzania
ATE455778T1 (de) * 2003-11-03 2010-02-15 Cadila Healthcare Ltd Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
WO2005080890A1 (de) * 2004-02-24 2005-09-01 Siegfried Generics International Ag Pharmakologisch akzeptierbare salze von clopidogrel
UA84335C2 (ru) * 2004-04-20 2008-10-10 Санофи Авентис Клопидогрель и его полиморфные формы
WO2006074066A1 (en) * 2004-12-30 2006-07-13 Nektar Therapeutics Non-crystalline formulation comprising clopidogrel
WO2007052300A2 (en) 2005-09-05 2007-05-10 Cadila Healthcare Limited Processes for the preparation of different forms of (s)-(+)-clopidogrel besylate
EP1903046B1 (en) * 2006-09-25 2011-02-16 Adamed SP. Z O.O. New clopidogrel salt and its crystalline forms
KR101378596B1 (ko) 2006-12-27 2014-03-26 경동제약 주식회사 결정성 클로피도그렐 · 황산염 형태 ｉ의 제조방법
US7935697B2 (en) 2006-12-28 2011-05-03 Kinex Pharmaceuticals, Llc Compositions for modulating a kinase cascade and methods of use thereof
KR100805675B1 (ko) 2007-03-07 2008-02-21 한림제약(주) 클로피도그렐 베실레이트를 포함하는 약학 조성물 및 그의제조방법
EP2062909A1 (en) * 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Peptide production and purification process
KR100920932B1 (ko) * 2007-12-05 2009-10-20 한림제약(주) 결정형의 클로피도그렐 벤젠술폰산염의 제조방법
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
WO2012123958A1 (en) 2011-02-14 2012-09-20 Cadila Healthcare Limited Highly pure salts of clopidogrel free of genotoxic impurities
CN102199161B (zh) * 2011-03-30 2013-07-03 天津红日药业股份有限公司 一种苯磺酸氯吡格雷晶型ⅰ及其制备方法和用途
CN102285996A (zh) * 2011-03-30 2011-12-21 天津红日药业股份有限公司 一种苯磺酸氯吡格雷晶型ⅱ及其制备方法和用途
CN104193762B (zh) * 2014-08-04 2017-02-15 浙江车头制药股份有限公司 一种制备苯磺酸氯吡格雷晶型ⅲ的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2779726B1 (fr) 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
US6509348B1 (en) 1998-11-03 2003-01-21 Bristol-Myers Squibb Company Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
DE19857137A1 (de) 1998-12-11 2000-06-15 Bayer Ag Integriertes Verfahren zur Herstellung von Epoxiden aus Olefinen
IN191030B (no) 2001-01-24 2003-09-13 Cadila Healthcare Ltd
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
WO2004074215A1 (en) 2003-02-03 2004-09-02 Sunil Sadanand Nadkarni Process for preparation of clopidogrel, its salts and pharmaceutical compositions
DE10305984A1 (de) 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
EP1603920A1 (en) 2003-03-12 2005-12-14 Cadila Healthcare Ltd. Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
PL1618111T3 (pl) 2003-04-25 2015-06-30 Cadila Healthcare Ltd Sole klopidogrelu i sposób wytwarzania
ATE455778T1 (de) 2003-11-03 2010-02-15 Cadila Healthcare Ltd Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
EP1900358A1 (en) 2006-09-16 2008-03-19 Cimex Pharma AG Pharmaceutical formulations comprising clopidogrel

Also Published As

Publication number Publication date
EP2865681A2 (en) 2015-04-29
US20100197923A1 (en) 2010-08-05
WO2004106344A2 (en) 2004-12-09
KR20060013376A (ko) 2006-02-09
DK1618111T3 (en) 2015-02-16
HRP20150056T1 (hr) 2015-04-24
DE04770646T1 (de) 2011-12-08
WO2004106344A3 (en) 2005-03-24
NO333586B1 (no) 2013-07-15
EP2113506A2 (en) 2009-11-04
EP1927595A2 (en) 2008-06-04
PT1618111E (pt) 2015-02-05
NO20054763D0 (no) 2005-10-17
EP1618111B1 (en) 2014-12-24
SI1618111T1 (sl) 2015-05-29
EP2113506A3 (en) 2010-02-24
EP1927595A3 (en) 2008-09-24
EP1618111A2 (en) 2006-01-25
PL1618111T3 (pl) 2015-06-30
US8053579B2 (en) 2011-11-08
US7732608B2 (en) 2010-06-08
CY1116554T1 (el) 2017-03-15
ES2531088T3 (es) 2015-03-10
EP2865681A3 (en) 2015-08-19
US20060264636A1 (en) 2006-11-23
EP1927595B1 (en) 2013-03-06

Similar Documents

Publication Publication Date Title
NO20054763L (no) Salter av clopidogrel og fremgangsmate for fremstilling derav
NO20062335L (no) Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer
NO20055219L (no) Nye forbindelser
NO20044826L (no) Pyrrolidinderivater
SE0202463D0 (sv) Novel compounds
NO20060001L (no) Nye P2X7-reseptorantagonister og deres anvendelse
NO20023037D0 (no) Nye piperidin- og piperazinderivater
NO20085373L (no) P38 inhibitorer, deres fremstilling og anvendelse
NO20092723L (no) Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer
NO20093060L (no) Spirosykliske sykloheksanderivater
NO20091893L (no) Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav.
GEP20084435B (en) Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
NO20050164L (no) Nye quinuklidin-amid-derivater
BR0208741A (pt) Derivados de piperidina
NO20076695L (no) Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser
NO20075059L (no) Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase
NO20085087L (no) Nye heterocykliske forbindelser
NO20051695L (no) Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer
NO20071137L (no) Nye piperidinderivater for behandling av depresjon
ATE386725T1 (de) Heterocyclylverbindungen
DK1546127T3 (da) Nye pyrimidinamidderivater og anvendelse deraf
DK1674456T3 (da) Nye 1,4-benzothiazepin-1,1-dioxid-derivater med forbedrede egenskaber, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
NO20052182L (no) Nye forbindelser
NO20060146L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
DE60108626D1 (de) Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b] pyridinen als cyclin-abhängige kinase-hemmer

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees